Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1932 1
1940 2
1951 1
1955 1
1957 1
1960 1
1964 2
1965 1
1972 2
1973 11
1974 11
1975 2
1976 3
1977 12
1978 4
1979 7
1980 10
1981 16
1982 17
1983 11
1984 7
1985 13
1986 11
1987 13
1988 13
1989 20
1990 16
1991 10
1992 24
1993 23
1994 16
1995 11
1996 19
1997 22
1998 20
1999 21
2000 26
2001 25
2002 21
2003 9
2004 14
2005 11
2006 19
2007 6
2008 11
2009 14
2010 20
2011 20
2012 39
2013 16
2014 19
2015 19
2016 22
2017 19
2018 26
2019 29
2020 36
2021 48
2022 21
Text availability
Article attribute
Article type
Publication date

Search Results

824 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines.
Tieu J, Smith R, Basu N, Brogan P, D'Cruz D, Dhaun N, Flossmann O, Harper L, Jones RB, Lanyon PC, Luqmani RA, McAdoo SP, Mukhtyar C, Pearce FA, Pusey CD, Robson JC, Salama AD, Smyth L, Watts RA, Willcocks LC, Jayne DRW. Tieu J, et al. Among authors: jones rb. Rheumatology (Oxford). 2020 Apr 1;59(4):e24-e32. doi: 10.1093/rheumatology/kez640. Rheumatology (Oxford). 2020. PMID: 32096545 No abstract available.
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.
Smith RM, Jones RB, Specks U, Bond S, Nodale M, Aljayyousi R, Andrews J, Bruchfeld A, Camilleri B, Carette S, Cheung CK, Derebail V, Doulton T, Forbess L, Fujimoto S, Furuta S, Gewurz-Singer O, Harper L, Ito-Ihara T, Khalidi N, Klocke R, Koening C, Komagata Y, Langford C, Lanyon P, Luqmani RA, Makino H, McAlear CA, Monach P, Moreland LW, Mynard K, Nachman P, Pagnoux C, Pearce F, Peh CA, Pusey C, Ranganathan D, Rhee RL, Spiera R, Sreih AG, Tesar V, Walters G, Weisman MH, Wroe C, Merkel PA, Jayne D; RITAZAREM coinvestigators; RITAZAREM co-investigators. Smith RM, et al. Among authors: jones rb. Ann Rheum Dis. 2020 Sep;79(9):1243-1249. doi: 10.1136/annrheumdis-2019-216863. Epub 2020 Jun 24. Ann Rheum Dis. 2020. PMID: 32581088 Free PMC article.
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh D, Walsh M, Westman K, Jayne DR; European Vasculitis Study Group. Jones RB, et al. N Engl J Med. 2010 Jul 15;363(3):211-20. doi: 10.1056/NEJMoa0909169. N Engl J Med. 2010. PMID: 20647198 Free article. Clinical Trial.
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.
Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J, Hamour S, Burns A, Griffith M, Galliford J, Levy JB, Cairns TD, Gopaluni S, Jones RB, Jayne D, Little MA, Pusey CD, Salama AD. Pepper RJ, et al. Among authors: jones rb. Rheumatology (Oxford). 2019 Feb 1;58(2):260-268. doi: 10.1093/rheumatology/key288. Rheumatology (Oxford). 2019. PMID: 30239910 Free article.
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR; European Vasculitis Society (EUVAS). Jones RB, et al. Ann Rheum Dis. 2015 Jun;74(6):1178-82. doi: 10.1136/annrheumdis-2014-206404. Epub 2015 Mar 4. Ann Rheum Dis. 2015. PMID: 25739829 Clinical Trial.
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.
Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A, Cid MC, Dahlsveen K, de Zoysa J, Espigol-Frigolé G, Lanyon P, Peh CA, Tesar V, Vaglio A, Walsh M, Walsh D, Walters G, Harper L, Jayne D; European Vasculitis Study Group (EUVAS). Jones RB, et al. Ann Rheum Dis. 2019 Mar;78(3):399-405. doi: 10.1136/annrheumdis-2018-214245. Epub 2019 Jan 5. Ann Rheum Dis. 2019. PMID: 30612116 Clinical Trial.
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.
Keller MD, Harris KM, Jensen-Wachspress MA, Kankate VV, Lang H, Lazarski CA, Durkee-Shock J, Lee PH, Chaudhry K, Webber K, Datar A, Terpilowski M, Reynolds EK, Stevenson EM, Val S, Shancer Z, Zhang N, Ulrey R, Ekanem U, Stanojevic M, Geiger A, Liang H, Hoq F, Abraham AA, Hanley PJ, Cruz CR, Ferrer K, Dropulic L, Gangler K, Burbelo PD, Jones RB, Cohen JI, Bollard CM. Keller MD, et al. Among authors: jones rb. Blood. 2020 Dec 17;136(25):2905-2917. doi: 10.1182/blood.2020008488. Blood. 2020. PMID: 33331927 Free PMC article.
Immunological approaches to HIV cure.
Ward AR, Mota TM, Jones RB. Ward AR, et al. Among authors: jones rb. Semin Immunol. 2021 Jan;51:101412. doi: 10.1016/j.smim.2020.101412. Epub 2020 Sep 24. Semin Immunol. 2021. PMID: 32981836 Free article. Review.
ADHD in adults with recurrent depression.
Powell V, Agha SS, Jones RB, Eyre O, Stephens A, Weavers B, Lennon J, Allardyce J, Potter R, Smith D, Thapar A, Rice F. Powell V, et al. Among authors: jones rb. J Affect Disord. 2021 Dec 1;295:1153-1160. doi: 10.1016/j.jad.2021.09.010. Epub 2021 Sep 11. J Affect Disord. 2021. PMID: 34706428 Free PMC article.
Treatment of Relapses in ANCA-Associated Vasculitis.
McClure M, Jones RB. McClure M, et al. Among authors: jones rb. Clin J Am Soc Nephrol. 2019 Jul 5;14(7):967-969. doi: 10.2215/CJN.06250519. Epub 2019 Jun 28. Clin J Am Soc Nephrol. 2019. PMID: 31278112 Free PMC article. No abstract available.
824 results